S. Rezaeian et al.: 6H-Benzotetrazolothiadiazineꢂꢁꢀꢀꢀꢂ341
7
,7-Dimethyl-9-piperidino-7,8-dihydro-6H-tetrazolo[1,5-b][4,1,2]
[5] Shivarama, H. B.; Akberali, P. M.; Shivananda, M. K. Studies on
nitrophenylfuran derivatives: part XII. Synthesis, characteriza-
tion, antibacterial and antiviral activities of some nitrophenyl-
furfurylidene-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines. Farmaco
2001, 56, 919–927.
[6] Al-Masoudi, N. A.; Al-Soud, Y. A. New sulphonamide and
carboxamide derivatives of acyclic c-nucleosides of triazolo-
thiadiazole and the thiadiazine analogues. Synthesis, anti-HIV,
and antitumor activities. Part 2. Nucleosides Nucleotides
Nucleic Acids 2008, 27, 1034–1044.
[7] Bhat, K. S; Poojary, B.; Prasad, D. J.; Naik, P.; Holla, B. S.
Synthesis and antitumor activity studies of some new fused
1,2,4-triazole derivatives carrying 2,4-dichloro-5 fluorophenyl
moiety. Eur. J. Med. Chem. 2009, 44, 5066–5070.
[8] El Shehry, M. F.; Abu-Hashem, A. A.; El-Telbani, E. M. Synthesis
of 3-((2,4-dichlorophenoxy)methyl)-1,2,4-triazolo(thiadiazoles
and thiadiazines) as anti-inflammatory and molluscicidal
agents. Eur. J. Med. Chem. 2010, 45, 1906–1911.
[9] Albrecht, W. L.; Sweet, F. W. Triazolobenzocycloalkylthiadiazine
derivatives. Chem. Abstr. 1976, 85, 78172g.
benzothiadiazine (6c):ꢀTLC solvent: acetate/n-hexane 2:1; yield
1
7
3%; powder; mp 187–188°C; H NMR (100 MHz): 1.10 (s, 6H, 2CH ),
3
1
.60–1.80 (m, 6H, 3CH ), 2.35 (s, 2H, CH ), 2.50 (s, 2H, CH ), 2.90–3.10
2
2
2
-1
(
m, 4H, 2CH N); IR: ν 2966 (CH ), 2936 (CH ), 1552 cm (C ꢀ= ꢀN ); MS:
2
3
2
m/z 304. Anal. Calcd for C H N S: C, 55.24; H, 6.62; N, 27.61; S, 10.53.
14
20
6
Found: C, 55.19; H, 6.58; N, 27.57; S, 10.47.
7
,7-Dimethyl-9-(4-methylpiperazino)-7,8-dihydro-6H-tetrazolo-
[
1,5-b][4,1,2] benzothiadiazine (6d):ꢀTLC solvent: acetate/n-hexane
1
2
:1; yield 68%; powder; mp 117–119°C; H NMR (100 MHz): 1.10 (s, 6H,
2
CH ), 2.40 (s, 5H, N-CH , and CH ), 2.50 (s, 2H, CH ), 2.50–2.70 (m, 4H,
3
3
2
2
-1
CH N), 2.90–3.01 (m, 4H, CH N); IR: ν 2960 (CH ), 2932 (CH ), 1557 cm
2
2
3
2
(C ꢀ= ꢀN ); MS: m/z 319. Anal. Calcd for C H N S: C, 52.64; H, 6.63; N, 30.69;
14 21 7
S, 10.04. Found: C, 52.58; H, 6.58; N, 30.62; S, 9.97.
9
-(4-Ethylpiperazino)-7,7-dimethyl-7,8-dihydro-6H-tetrazolo[1,5-
b][4,1,2] benzothiadiazine (6e):ꢀTLC solvent: acetate/n-hexane 2:1;
1
yield 70%; mp 145–147°C; H NMR (250 MHz): δ 1.22 (s, 6H, 2CH ), 1.25
3
(
t, 3H, CH3), 2.5 (s, 2H, CH ), 2.7 (s, 2H, CH ), 2.81–3.21 (m, 6H, 3CH ),
2
2
2
13
3
.31–3.41 (m, CH ). C NMR (100 MHz): 156.4, 154.7, 141.7, 77.5, 77.2, 77, [10] Brucato, A.; Coppola, A.; Gianquzza, S.; Provenzano, P. M.
2
7
6.5, 52.2, 47.7, 45.2, 41.1, 30.4, 27.8, 27.5, 11.3; IR: ν 2957 (CH ), 2809
Triazolam: characteristics of its depressive action. Boll. Soc.
Ital. Biol. Sper. 1978, 54, 1051–1057.
[11] Albrecht, W. L.; Jones, W. D. Triazolocycloalkylhydrothiadiazine
derivatives. Chem. Abstr. 1976, 85, 177501v.
3
-1
(
CH ), 1562 cm (C ꢀ= ꢀN ); MS: m/z 333. Anal. Calcd for C H N S: C, 54.03;
2
1
5
2
3
7
H, 6.95; N, 29.40; S, 9.62. Found: C, 53.98; H, 6.91; N, 28.36; S, 9.58.
7
,7-Dimethyl-9-(4-phenylpiperazino)-7,8-dihydro-6H-tetrazolo[1,5- [12] Čačić, M.; Pavić, V.; Molnar, M.; Šarkanj, B.; Has-Schon, E.
b][4,1,2]benzothiadiazine (6f):ꢀTLC solvent: acetate/n-hexane 2:1;
Design and synthesis of some new 1,3,4-thiadiazines with
coumarin moieties and their antioxidative and antifungal
activity. Molecules 2014, 19, 1163–1177.
1
yield 68%; powder; mp 124–126°C; H NMR (250 MHz): 1.04 (s, 6H, 2CH ),
3
2
.33 (s, 2H, CH ), 2.43 (s, 2H, CH ), 3.00–3.40 (m, 8H, 4CH ), 6.75–7.5 (m,
2
2
2
-1
5
H, aromatic); IR: ν 3060 (aromatic H), 2958 (CH ), 2880 (CH ), 1599 cm
[13] Sadoshima, J. Novel AT1 receptor-independent functions of
losartan. Circ. Res. 2002, 90, 754–756.
3
2
13
(
C ꢀ= ꢀN ); C NMR (250 MHz): 156.3, 154.8, 150.7, 129.3, 116.6, 77.52, 77, 76.5,
4
9.5, 48.4, 45.2, 41.3, 30.5, 27.8; MS: m/z 381. Anal. Calcd for C H N S: C, [14] Kubo, K.; Kohara, Y.; Imamiya, E.; Sugiura, Y.; Inada, Y.;
19 23 7
59.82; H, 6.08; N, 25.70; S, 8.41. Found: C, 59.78; H, 5.97; N, 25.69; S, 8.37.
Furukawa, Y. Nonpeptide angiotensin II receptor antagonists.
Synthesis and biological activity of benzimidazolecarboxylic
acids. J. Med. Chem. 1993, 36, 2182–2195.
[
15] Eftekhar, M.; Eshghi, H.; Rahimizadeh, M.; Bakavoli, M.;
Saberi, S. Facile synthesis of some novel 6-alkyl or aryl-
References
7
H-tetrazolo[5,1-b][1,3,4]thiadiazine. J. Chem. Res. 2014, 38,
[
1] Mehlika, D. A.; Zafer, A.; Kaplanc, K. L.; Gülhan, T. Z. Synthesis
and anticandidal activity of new triazolothiadiazine derivatives.
Eur. J. Med. Chem. 2011, 46, 5562–5566.
365–367.
[16] Almajan, G. L.; Barbuceanu, S. F.; Sarmet, L.; Draghici, C. New
6-amino-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]
triazolo[3,4-b] [1,3,4]thiadiazin-6-ones: synthesis, characteri-
zation and antibacterial activity evaluation. Eur. J. Med. Chem.
2010, 45, 3191–3195.
[
2] Holla, B. S.; Rao, B. S.; Sarojini, B. K.; Akberali, P. M.; Kumari,
N. S. Synthesis and studies on some new fluorine containing
triazolothiadiazines as possible antibacterial, antifungal and
anticancer agents. Eur. J. Med. Chem. 2006, 41, 657–663.
3] Ravi, G.; Ravinder Nath, A.; Nagaraj, A.; Damodhar, S.;
Nageshwara, R. G. Synthesis and antibacterial activity of
[17] Eshghi, H.; Rahimizadeh, M.; Saberi, S.; Abnous, K.; Bakavoli,
M. Pyrimido[5,4-e]tetrazolo[5,1-b][1,3,4]thiadiazines as a new
heterocyclic system. J. Chem. Res. 2013, 9, 553–555.
[18] Alexander, R.; Balasundaram, A.; Batchelor, M.; Brookings,
D.; Crépy, K.; Crabbe, T.; Deltent, M. F.; Driessens, F.; Gill, A.;
Harris, S.; et al. 4-(1,3-Thiazol-2-yl)morpholine derivatives as
inhibitors of phosphoinositide 3-kinase. Bioorg. Med. Chem.
Lett. 2008, 18, 4316–4320.
[
[
3
-(5-methyl-1-phenyl-1H-1,2,3-triazol-4-yl)-6-aryl-7H-[1,2,4]
triazolo[3,4-b][1,3,4]thiadiazine. Der. Pharm. Chem. 2014, 6,
23–232.
2
4] Khan, I.; Zaib, S.; Ibrar, A.; Rama, N. H.; Simpson, J.; Iqbal, J.
Synthesis, crystal structure and biological evaluation of
some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and
[19] Kosmrlj, J.; Kocevar, M.; Poland, S. A new convenient bro-
1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines. Eur. J. Med. Chem. 2014,
78, 167–177.
mination with KBrO /KBr/Dowex. Synth. Commun. 1996, 26,
3
3583–3592.
Brought to you by | New York University Bobst Library Technical Services
Authenticated
Download Date | 5/21/15 5:41 AM